Papers
1
Total Citations
40
H-Index
1
About
Naoki Goshima is a distinguished researcher in chemical biology and cell-based assay development, with a primary focus on identifying novel small-molecule inhibitors of key cellular enzymes. His most impactful work centers on the discovery of flavone as a tankyrase inhibitor, a breakthrough achieved through a novel yeast cell-based screening platform. This 2010 study, which has garnered 40 citations, demonstrates Goshima’s innovative approach to drug discovery, leveraging yeast genetics to uncover compounds that modulate telomere maintenance and Wnt signaling pathways—critical areas in cancer research. By designing a robust, high-throughput system, he provided a powerful tool for probing tankyrase function, opening new avenues for therapeutic intervention. Goshima’s contributions bridge fundamental cell biology and translational medicine, offering a model for how creative screening strategies can yield bioactive molecules. His work is particularly notable for its methodological elegance, enabling researchers to bypass traditional biochemical assays and directly assess compound effects in living cells. For students and scientists exploring chemical genetics or targeted cancer therapies, Goshima’s research exemplifies the synergy between assay engineering and drug discovery, underscoring the value of interdisciplinary approaches in tackling complex biological questions.
Research Focus
Key Achievements
Top Papers
- 1A novel yeast cell-based screen identifies flavone as a tankyrase inhibitor40 citations · 2010